RCEL Kronos AI forecast
A 30-trading-day price forecast for Avita Medical Inc. (RCEL) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Avita Medical Inc. at $6.16 on 2026-12-08, −61.7% from the last close of $16.08 on 2026-10-27. Eight out of ten sampled paths end between $5.39 and $7.17, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of RCEL
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $15.64 | $14.73 | $18.18 |
| 2026-11-10 | $9.00 | $4.82 | $13.56 |
| 2026-11-17 | $7.09 | $5.30 | $8.95 |
| 2026-11-24 | $6.71 | $5.10 | $7.80 |
| 2026-12-01 | $5.83 | $5.11 | $7.41 |
| 2026-12-08 | $6.16 | $5.39 | $7.17 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for RCEL?
- Kronos AI's median forecast for RCEL is $6.16 in 30 trading days, −61.7% from the last close, with a 10–90% range of $5.39 to $7.17.
- Is the RCEL Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- SYK — Stryker Corporation
- MMM — 3M Company
- BSX — Boston Scientific Corporation
- BDX — Becton Dickinson and Company
- MDLN — Medline Inc.
- RMD — ResMed Inc.